Publications by authors named "Vijay P Sn"
Due to the increased burden of chronic medical conditions in recent years, artificial intelligence (AI) is suggested in the medical field to optimize health care. Physicians could implement these automated problem-solving tools for their benefit, reducing their workload, assisting in diagnostics, and supporting clinical decision-making. These tools are being considered for future medical assistance in real life.
View Article and Find Full Text PDFArticle Synopsis
- Sotagliflozin, after FDA approval following significant trials, has become a pioneering drug for treating heart failure in Type 2 diabetes patients.
- A systematic review was conducted comparing cardioprotective effects and mortality rates of sotagliflozin and dapagliflozin, revealing that sotagliflozin notably decreases cardiovascular mortality and hospitalizations when initiated timely.
- The underlying mechanisms for the benefits of SGLT-2 inhibitors, like diuretic effects and reductions in glycemic toxicity, are complex, contributing to their cardioprotection in patients with heart failure.
Several studies have shown that an association exists between hyperuricemia and heart failure. Despite several innovative management strategies, heart failure is a significant cause of mortality worldwide. Hyperuricemia in heart failure patients leads to poorer outcomes.
View Article and Find Full Text PDFSudden cardiac death (SCD) is a condition that accounts for a high percentage of cardiovascular fatalities, with ventricular tachyarrhythmias being the most common cause. There are signs and symptoms of SCD that occur spontaneously without any warning and are deadly. Despite preventative efforts focusing on the use of subcutaneous implanted cardioverter defibrillators (S-ICD) in the highest-risk population categories, a high number of SCDs occur in the normal population and in people who do not have a documented cardiac condition.
View Article and Find Full Text PDF